Life Sciences Spinouts from In-License to Exit – Key Issues for Success

Adam Falconi is an Associate at Mintz who focuses his practice on corporate law, financing, and technology transactions in the life sciences and health technology industries. He represents a range of life science and health care companies, as well as venture capital and private equity funds.